跳至主要内容
临床试验/CTRI/2014/05/004637
CTRI/2014/05/004637招募中4 期

Clinical Experience with ertapenem in acute pyelonephritis due to ESBL producing enterobacteriaceae

MSD Pharmaceuticals0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • ï??Age: â?§18 years
  • ï??Diagnosis of Acute Pyelonephritis [i.e., patients with fever, flank pain or costvertebral angle tenderness, pyuria (>= 10 white blood cell per high power field)] and confirmed ESBL Enterobacteriaceae (as per CLSI, Vitek-2) on urine culture
  • ï??Patient received Ertapenem therapy (>=3 dose)

排除标准

  • ï??Need for concomitant antimicrobials in addition to study therapy
  • ï??A history of coronary heart disease or stroke, serum Creatinine >1.5 mg/dl, albuminuria >40 μg/min, and use of lipid-lowering drugs, aspirin, or other antihypertensive agents.

研究者

发起方
MSD Pharmaceuticals

相似试验